Why Am I Getting a Blood Thinner in the Hospital?

Why hospitals commonly do this

Hospitalization can temporarily combine several clot risks, including acute illness, surgery or injury, inflammation, reduced movement, and a person's existing risk factors.

• A clinician may order an anticoagulant to prevent deep-vein thrombosis or pulmonary embolism while a patient is less mobile or acutely ill.
• Another patient may receive an anticoagulant to treat a known clot or reduce clot or stroke risk from a different condition.
• Mechanical prevention, such as compression devices and walking when permitted, may be used instead of or alongside medication depending on the situation.

From the bedside: mobility is part of the prevention plan

Patients may experience the injection as the whole plan, while the bedside team is also watching how much the patient is actually moving and whether mechanical prevention is being used correctly.

• When the care team says it is safe, sitting in the chair for meals, walking, and participating with physical or occupational therapy can support recovery and reduce immobility.
• Ordered sequential compression devices only help when they are worn and functioning as directed.
• A patient who is worried about an injection can ask whether walking, compression devices, or another option is appropriate—but the answer depends on the patient's clot and bleeding risks.
• Movement and compression devices are not automatic substitutes for anticoagulant medication; the team may recommend one, the other, or both.

What this does not necessarily mean

• It does not necessarily mean the team found a blood clot.
• It does not mean every hospitalized patient should receive the same medicine.
• It does not mean heparin, enoxaparin, apixaban, rivaroxaban, and aspirin can be substituted for one another.
• It does not mean the medicine should automatically continue after discharge.

How the commonly named options differ

The bedside team chooses among medication classes and routes based on the indication, timing, procedures, organ function, bleeding risk, and the broader treatment plan.

• Unfractionated heparin may be given under the skin for prevention or through an IV for certain treatment situations; monitoring needs can differ by use.
• Enoxaparin (Lovenox) is a low-molecular-weight heparin commonly given by injection and used for prevention or treatment in selected situations.
• Apixaban (Eliquis) and rivaroxaban (Xarelto) are oral factor Xa inhibitors used for specific prevention and treatment indications.
• Aspirin affects platelets and is generally described as an antiplatelet medicine rather than the same type of anticoagulant as heparin or the oral factor Xa inhibitors.

Important variables and exceptions

• Why it is being used: prevention, treatment of a known clot, stroke prevention, a heart-related indication, or another reason.
• Kidney and liver function, platelet count, recent bleeding, anemia, age, weight, pregnancy status, and other clinical factors.
• Upcoming surgery, procedure, spinal or epidural care, line placement, or a need for the effect to wear off at a predictable time.
• Other prescriptions, over-the-counter medicines, supplements, and prior reactions that could change bleeding or clotting risk.
• Whether walking, compression devices, or another prevention approach is appropriate when medication is delayed, declined, or contraindicated.

What information to bring or verify

• An accurate list of prescriptions, over-the-counter medicines, vitamins, and supplements, including the last dose taken.
• Any current or previous blood thinner or antiplatelet medicine and why it was prescribed.
• Prior major bleeding, stomach or intestinal bleeding, brain bleeding, clotting problems, low platelets, heparin-induced thrombocytopenia, falls, or recent head injury.
• Planned procedures and the name of the clinician who manages a long-term anticoagulant when applicable.

When to notify the bedside team promptly

While hospitalized, use the call button or tell the nurse or care team immediately about new or unexpected bleeding concerns rather than waiting for the next scheduled visit.

• Bleeding that does not stop, blood in urine or stool, black stool, vomiting or coughing blood, or a rapidly enlarging bruise.
• A fall, head strike, new severe headache, sudden weakness, fainting, chest pain, shortness of breath, or another sudden change.
• A medication allergy, prior heparin reaction, missed home anticoagulant doses, or an upcoming procedure the team may not know about.

Educational limits

This page explains common hospital reasoning. It cannot determine whether a blood thinner is appropriate, safe, correctly dosed, or necessary for a particular person.

• The treating team has the diagnosis, examination, laboratory results, procedure schedule, medication record, and patient-specific risks.
• Do not independently start, stop, skip, substitute, split, or change a blood thinner dose.
• If a patient wants to decline or delay a dose, ask for the reason, risks, alternatives, and follow-up plan before deciding when the situation allows.